CTMX

$5.45

Pre-MarketAs of Mar 17, 8:00 PM UTC

CytomX Therapeutics, Inc.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Recent News

Zacks
Mar 17, 2026

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

CytomX Therapeutics stock surges 44% after phase I data for Varseta-M in heavily pretreated metastatic CRC show rising response rates and strong disease control.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Motley Fool
Mar 16, 2026

Stock Market Today, March 16: CytomX Therapeutics Surges After Positive Phase 1 Colorectal Cancer Data

Today, March 16, 2026, investors weigh striking early colorectal cancer results against weak quarterly numbers and a finite cash runway.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
MT Newswires
Mar 16, 2026

Sector Update: Health Care Stocks Advance Late Afternoon

Health care stocks rose late Monday afternoon, with the NYSE Health Care Index up 0.8% and the State

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
GuruFocus.com
Mar 16, 2026

CytomX Therapeutics Inc (CTMX) Q4 2025 Earnings Call Highlights: Promising Phase 1 Data and ...

CytomX Therapeutics Inc (CTMX) reports encouraging results from its Varseta-M study, with plans for a pivotal trial and expansion into new tumor types.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Associated Press Finance
Mar 16, 2026

BC-Most Active Stocks

YY Group Holdings Ltd. 26,117,734 0.0511

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.